Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Monday July 8

j, L
Monday

MoPeB33o4 Antiretroviral therapy (ART) use, adherence and HIV
care in Massachusetts regional primary care sites
L M Kunches, L R Hirschhorn, N E Reinhalter,
J B Decristofaro, P Lawrence, J Musolino,
E Coakley, J F McGuire, MA ACTNow Working
Group (United States)
MoPeB33o5 Are HIV-patients just like other chronically ill?
C F Hekkink, P JE Bindels, K Brinkman, J TM van
der Meer, L Wigersma, C]J Yzermans, SA Danner
(The Netherlands)
MoPeB33o6 HAART from the patient's perspective: quality of
informed consent
G Meystre-Agustoni, F Dubois-Arber, P Morency,
P Cochand, A Telenti, A Jeannin, B Spencer, Swiss
HIV Cohort Study (Switzerland)
MoPeB33o7 Commitment with people living with HIV/AIDS:
improving quality of care in Brazil
M I Battistella Nemes ER L Castanheira,
R Melchior, CR Basso, M T S Britto e Alves,
A Donini, J S E David, P Braga, L G Tunala,
S C Melchior (Brazil)
MoPeB33o8 Quality of care assessement in STD/AIDS health
services in Sao Paulo, Brazil
M / Battistella Nemes, RMelchior, A Donini,
CR Basso, ER L Castanheira, M T S Britto e Alves,
J S E David, P Braga, L G Tunala (Brazil)
MoPeB33o9 Using an electronic medical record to improve
H IV care
B E Johnston, R L Leon, K R Ong (United States)
MoPeB331o Using theater-based methods to train HIV care
providers to screen and refer patients to intimate
partner and sexual violence services
C Berlin, C Paley, S Xenarios, A Blank, D Hien,
V Frye, V Sharp (United States)
MoPeB3311 The impact of HIV/AIDS related morbidity and
mortality in a rural district hospital in South Africa
M Dedicoat', A Reid2, D Mbatha', C Gilks2
('South Africa; 2United Kingdom)
MoPeB3312 Changing the role of the pharmaceutical care in
the AIDS Brazilian AIDS Program
S C Melchior DA Soares, A M Ivama,
M/ I Battistella Nemes (Brazil)
MoPeB3313 Standard of care in H IV management - is the
percentage of patients with undetectable viral
load a robust marker?
G R Scott (United Kingdom)
MoPeB3314 Missed opportunities for prevention:
Pneumocystis carinii pnemonia (PCP) and PCP
mortality among persons with H IV infection,
South Carolina and Puerto Rico
C M Beck-Saque', R Andress', C Zorrilla2,
J Suarez2, M Singleton', H Jaffe'
(United States; 2Puerto Rico)
MoPeB3315 Variation in HIV ambulatory care clinic
performance: a retrospective multicenter study
E JKorner R A Bankowitz, I L Cerese,
MA Keroack, T Li, A W Wu (United States)
MoPeB3316 Antiretrovirals (ARVs) in India-a challenge with
two edges
A K Deshpande, S B Vaidya (India)
MoPeB3317 Appropriateness of discontinuations (Ds) or noncommencement after previous interruption
(NCAI) HIV therapy in hospitalised patients
FSuter, CArici, M Rizzi, D Ripamonti, GAntesana,
F Maggiolo, B Marini, L Ravasio (Italy)
MoPeB3318 The role of palliative day care centres in the Free

State, South Africa, in improving quality of life in
children infected and affected by HIV and AIDS
K Sephiri (South Africa)

MoPeB3319 Patient-reported indicators of the quality of
outpatient care for HIV/AIDS
A W Wu A Skinner, L Dunn (United States)
MoPeB332o Employment law and HIV/AIDS in workplaces,
Tanzania
L Lengaki, Z M Msumi (Tanzania)
MoPeB3321 Should locally relevant research in resource poor
settings be prohibited by "best proven"
standards of care: ethical beliefs in an
international sample of researchers
D M Kent', M Mwamburi', R Cash', TRabin',
M L Bennish2 (United States; 2South Africa)
MoPeB3322 Patients explain why they quit medical follow-up:
ethical research in a French clinical cohort of
HIV-infected patients
B Lebouche Y Yazdanpanah, Y Gerard, I Alcaraz,
P Boitte, B Cadore, Y Mouton (France)
MoPeB3323 AIDS education as component of physicians'
attestation in Russia
V M Kolesoy, V I Hasieva (Russian Federation)
MoPeC3324 Response to 20 years of the HIV/AIDS epidemic
in New York: Potential relevance for South Africa
D Hoos, Z Stein (United States)
MoPeC3325 Seroprevalence of HIV-1 and 2 antibodies in
Lagos, Nigeria over a o10-year period
S B S Badaru', B N Thomas', F K Ariyo',
S A Omilabu3 ('Nigeria; 2United States;
3Germany)
MoPeC3326 Spectrum of mortality due to human
immunodeficiency virus: analysis of 253 deaths
during 1994-2001
L Martin Carbonero, I Garcia Samaniego,
M Lopez, V Soriano, P Barreiro, V Moreno,
F Blanco, T Garcia-Benayas, I Gonzalez-Lahoz
(Spain)
MoPeC3327 Trend of infectious diseases and neoplasms as
associated causes of deaths from AIDS, State of
Sao Paulo, Brazil, 1997 to 2001
A H Santo I L FSantos, M S Jordani (Brazil)
MoPeC3328 Trend and spectrum of mortality among HIV
patients, in the era of HAART - the Nigerian
experience
E E Ekong, 0 Akinlade, A Uwah, I Grant-Isibor,
T Igbu (Nigeria)
MoPeC3329 Trends of AIDS cases and AIDS - defining
illnesses in Lyon University Hospitals (France)
between 1985 and 2000
A Gayet D Baratin, E Marceillac, D Peyramond,
C Trepo, J L Touraine, C Chidiac, J Ritter, ] Fabry,
P Vanhems (France)
MoPeC333o Characteristics of patients with a short delay
between first HIV positive screening test and
diagnosis of AIDS at Lyon University Hospitals,
France (1985-2000)
D Baratin, A Gayet, E Marceillac, D Peyramond,
C Trepo, I L Touraine, C Chidiac, I Ritter, I Fabry,
P Vanhems (France)
MoPeC3331 Mortality Decrease in patients with low HAART
utilization
IA Benetucci, SM Oliva, A Montero (Argentina)
MoPeC3332 Impact of HIV on child mortality in rural Tanzania
I Ng'weshemi', M Urassa', R Isingo', G Mwaluko',
I Ngalula', T Boerma2, B Zaba3
('Tanzania; 2United States; 3United Kingdom)
MoPeC3333 Congenital H IV - the world's leading birth defect
D E Bourne', B Borman2 ('South Africa;
2New Zealand)

42 Final Program